Table 3.
Parameters | Treatments
|
||
---|---|---|---|
Control | MCT+milk | MCT+Fasting | |
---------------------------0 h--------------------------- | |||
SCFA1 (%) | 1.80±0.05 | 2.01±0.48 | 1.45±0.85 |
MCFA2 (%) | 1.99±0.07a | 2.30±0.09ab | 31.27±6.67b |
LCFA3 (%) | 97.41±0.67b | 96.70±0.92b | 67.28±6.95a |
USFA4 (%) | 55.93±0.19b | 39.07±7.47b | 19.48±4.28a |
SSFA5 (%) | 44.07±0.19a | 60.93±7.47a | 80.52±4.28b |
Overall (mg/100 ml) | 143.50±11.20ab | 121.48±4.60a | 165.10±11.50b |
---------------------------2 h--------------------------- | |||
SCFA1 (%) | 1.05±0.25 | 1.73±0.38 | 1.91±0.76 |
MCFA2 (%) | 3.58±0.28a | 28.06±4.88b | 55.86±4.14c |
LCFA3 (%) | 95.90±0.81a | 70.21±4.54b | 43.50±4.16c |
USFA4 (%) | 44.00±11.00a | 30.59±1.96ab | 19.56±4.99b |
SSFA5 (%) | 56.00±11.00a | 69.40±1.96ab | 80.44±4.99b |
Overall (mg/100 ml) | 196.4±16.70 | 180.40±31.30 | 220.00±38.40 |
---------------------------4 h--------------------------- | |||
SCFA1 (%) | 2.04±0.03 | 1.80±0.45 | 3.30±2.72 |
MCFA2 (%) | 3.06±0.82a | 30.20±2.67b | 41.51±5.71b |
LCFA3 (%) | 95.59±1.49a | 67.99±2.44b | 56.28±7.31b |
USFA4 (%) | 53.42±0.95a | 36.28±1.69b | 22.01±6.02c |
SSFA5 (%) | 46.58±0.95a | 63.72±1.69b | 77.99±6.02c |
Overall (mg/100 ml) | 148.30±16.90 | 209.60±19.40 | 183.50±35.10 |
---------------------------6 h--------------------------- | |||
SCFA1 (%) | 1.25±0.13 | 1.57±0.36 | 0.86±0.25 |
MCFA2 (%) | 1.15±0.25a | 32.01±6.45b | 44.12±1.41b |
LCFA3 (%) | 98.92±0.13b | 66.43±6.44a | 55.59±1.17a |
USFA4 (%) | 38.30±18.30 | 30.48±2.80 | 21.60±0.72 |
SSFA5 (%) | 61.70±18.30 | 69.52±2.80 | 78.40±0.72 |
Overall (mg/100 ml) | 215.30±52.80 | 214.70±17.40 | 168.30±12.30 |
SCFA: Short-chain fatty acids (<C8);
MCFA: Medium-chain fatty acids (C8 to C12);
LCFA: Long-chain fatty acids (C13 to C20);
USFA: Unsaturated fatty acids;
SSFA: Saturated fatty acids.
n = 9. The results are presented as mean±standard error of mean (SEM).
Values within each row with different superscript were significantly differ (p<0.05).